INCYTE CORP 4

Pablo J. Cagnoni, President and Global Head of R&D of Incyte Corp (INCY), had a total of 22,919 shares of common stock withheld for tax obligations related to RSU/performance share settlements, valued at approximately $2.63 million in aggregate.

On July 14 and 15, 2026, Pablo J. Cagnoni, President and Global Head of R&D at Incyte Corp, had shares of common stock withheld by the company to satisfy tax withholding obligations upon settlement of previously granted RSUs or earned performance shares. The Form 4 reports that 17,969 shares were withheld on July 14 at an implied price of $114.88 per share (about $2.06 million in value) and 4,950 shares were withheld on July 15 at an implied price of $115.09 per share (about $0.57 million in value). These are non-discretionary, tax-related dispositions rather than open-market sales, and following the transactions Cagnoni directly owned 217,929 shares of Incyte common stock, excluding an additional 169,797 unvested shares underlying outstanding restricted stock units and performance shares.

Filing Facts

CIK

879169

Ticker

INCY

Form

4

Source Type

fda

Accession

0001205703-26-000019

Alert Tier

5